Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight.
Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight. Clin Endocrinol (Oxf). 2011 Jul; 75(1):76-82.